Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Catheter Ablation of Ventricular Tachycardia/Fibrillation in a Patient with Right Ventricular Amyloidosis with Initial Manifestations Mimicking Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

  • Chung, Fa-Po (Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital) ;
  • Lin, Yenn-Jiang (Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital) ;
  • Kuo, Ling (Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital) ;
  • Chen, Shih-Ann (Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital)
  • Received : 2016.09.21
  • Accepted : 2016.12.27
  • Published : 2017.03.31
⟨ Previous Next ⟩

Abstract

Differentiating arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) from other cardiomyopathies is clinically important but challenging. Although the modified Task Force Criteria can facilitate diagnosis of ARVD/C according to clinical manifestations, histopathological examination plays a pivotal role in excluding other diseases that can mimic ARVD/C. Here, we report a patient with amyloidosis that initially presented similarly to ARVD/C. The diagnosis was confirmed by endomyocardial biopsy, and catheter ablation eliminated the ventricular tachyarrhythmias through an epicardial approach.

Keywords

References

  1. Chung FP, Lin YJ, Chang SL, et al. Long-term follow-up of catheter ablation of ventricular arrhythmias: experiences from a tertiary referral center in Taiwan. Acta Cardiol Sin 2015;31:8-17.
  2. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J 2010;31:806-14. https://doi.org/10.1093/eurheartj/ehq025
  3. Chung FP, Lin YJ, Chang SL, et al. Current and state of the art on the electrophysiologic characteristics and catheter ablation of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiol 2015;65:441-50. https://doi.org/10.1016/j.jjcc.2014.12.023
  4. Mori M, Kitagawa T, Sasaki Y, et al. Long-term survival of a patient with multiple myeloma-associated severe cardiac AL amyloidosis after implantation of a cardioverter-defibrillator. Rinsho Ketsueki 2014;55:450-5.
  5. Frankel DS, Mountantonakis SE, Zado ES, et al. Noninvasive programmed ventricular stimulation early after ventricular tachycardia ablation to predict risk of late recurrence. J Am Coll Cardiol 2012;59:1529-35. https://doi.org/10.1016/j.jacc.2012.01.026
  6. Sacher F, Lim HS, Derval N, et al. Substrate mapping and ablation for ventricular tachycardia: the LAVA approach. J Cardiovasc Electrophysiol 2015;26:464-71. https://doi.org/10.1111/jce.12565